Literature DB >> 2966155

Identification of the phosphorylation sites in early region 1A proteins of adenovirus type 5 by amino acid sequencing of peptide fragments.

M L Tremblay1, C J McGlade, G E Gerber, P E Branton.   

Abstract

We have mapped the positions of three of the phosphorylation sites on the 289 and 243 residue (289R and 243R) early region 1A (E1A) proteins of human adenovirus type 5 (Ad5). These proteins, which play roles in both transcriptional control and oncogenic transformation, have identical sequences except for the presence in 289R of 46 additional internal amino acids. Phosphorylation was detected exclusively at serine residues. E1A proteins purified from [35S]methionine- or [32P]orthophosphate-labeled Ad5-infected cells were digested with trypsin, and two phosphopeptides were isolated by reverse-phase chromatography and subjected to automated Edman degradation. The major species was shown to contain a single phosphorylation site at Ser-219. The second phosphopeptide was shown to contain at least one phosphorylation site at Ser-231. A third phosphorylated tryptic peptide could not be eluted from the column but was isolated using an E1A-specific rat monoclonal antibody. Following subcleavage by Staphylococcus aureus V-8 protease, this peptide was shown to contain at least one phosphorylation site at Ser-89. The present data indicate that both the 289R and 243R E1A proteins are phosphorylated at the same sites, at least one in the amino terminal half of the molecule, and at least two toward the carboxyl terminus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966155

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  pRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption.

Authors:  L A Seifried; S Talluri; M Cecchini; L M Julian; J S Mymryk; F A Dick
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

2.  A protein kinase is present in a complex with adenovirus E1A proteins.

Authors:  T Kleinberger; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 3.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

4.  Activation in vitro of RNA polymerase II and III directed transcription by baculovirus produced E1A protein.

Authors:  G Patel; N C Jones
Journal:  Nucleic Acids Res       Date:  1990-05-25       Impact factor: 16.971

5.  Phosphorylation within the transactivation domain of adenovirus E1A protein by mitogen-activated protein kinase regulates expression of early region 4.

Authors:  S G Whalen; R C Marcellus; A Whalen; N G Ahn; R P Ricciardi; P E Branton
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes.

Authors:  A Mal; A Piotrkowski; M L Harter
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

7.  Importance of the Ser-132 phosphorylation site in cell transformation and apoptosis induced by the adenovirus type 5 E1A protein.

Authors:  S G Whalen; R C Marcellus; D Barbeau; P E Branton
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  AR1 is an integral part of the adenovirus type 2 E1A-CR3 transactivation domain.

Authors:  A C Ström; P Ohlsson; G Akusjärvi
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors.

Authors:  Jessica Komorek; Mohan Kuppuswamy; T Subramanian; S Vijayalingam; Elena Lomonosova; Ling-Jun Zhao; Joe S Mymryk; Kimberly Schmitt; G Chinnadurai
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

10.  Phosphorylation at the carboxy terminus of the 55-kilodalton adenovirus type 5 E1B protein regulates transforming activity.

Authors:  J G Teodoro; T Halliday; S G Whalen; D Takayesu; F L Graham; P E Branton
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.